Litcius/Paper detail

Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interaction

Raphaël Le Biannic, Romain Magnez, Frédérique Klupsch, Natascha Leleu‐Chavain, Bryan Thiroux, Morgane Tardy, Hassiba El Bouazzati, Xavier Dezitter, Nicolas Renault, Gérard Vergoten, Christian Bailly, Bruno Quesnel, Xavier Thuru, Régis Millet

2022European Journal of Medicinal Chemistry26 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryMicroscale thermophoresisADMEFörster resonance energy transferSmall moleculeMonoclonal antibodyImmune checkpointPyrazoloneIn vitroCancer researchBiochemistryReceptorAntibodyFluorescenceImmunologyBlockadeBiologyPhysicsQuantum mechanicsCancer Immunotherapy and BiomarkersProtein Tyrosine PhosphatasesComputational Drug Discovery Methods
Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interaction | Litcius